Université Paris Cité, INSERM UMR-1132, Bioscar, Hôpital Lariboisière, AP-HP, Paris, France.
Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, 34094, Montpellier, France.
Nat Commun. 2024 Sep 18;15(1):8179. doi: 10.1038/s41467-024-52543-8.
Deposition of monosodium urate and calcium pyrophosphate (MSU and CPP) micro-crystals is responsible for painful and recurrent inflammation flares in gout and chondrocalcinosis. In these pathologies, the inflammatory reactions are due to the activation of macrophages responsible for releasing various cytokines including IL-1β. The maturation of IL-1β is mediated by the multiprotein NLRP3 inflammasome. Here, we find that activation of the NLRP3 inflammasome by crystals and concomitant production of IL-1β depend on cell volume regulation via activation of the osmo-sensitive LRRC8 anion channels. Both pharmacological inhibition and genetic silencing of LRRC8 abolish NLRP3 inflammasome activation by crystals in vitro and in mouse models of crystal-induced inflammation. Activation of LRRC8 upon MSU/CPP crystal exposure induces ATP release, P2Y receptor activation and intracellular calcium increase necessary for NLRP3 inflammasome activation and IL-1β maturation. We identify a function of the LRRC8 osmo-sensitive anion channels with pathophysiological relevance in the context of joint crystal-induced inflammation.
单钠尿酸盐(MSU)和焦磷酸钙(CPP)微晶体的沉积是痛风和软骨钙质沉着症中引起疼痛和复发性炎症发作的原因。在这些病理中,炎症反应是由于负责释放包括白细胞介素 1β(IL-1β)在内的各种细胞因子的巨噬细胞的激活。IL-1β的成熟是由多蛋白 NLRP3 炎性小体介导的。在这里,我们发现晶体激活 NLRP3 炎性小体以及伴随的 IL-1β产生依赖于细胞体积调节,这是通过激活对渗透压敏感的 LRRC8 阴离子通道实现的。LRRC8 的药理学抑制和基因沉默均可在体外和小鼠晶体诱导的炎症模型中消除晶体对 NLRP3 炎性小体的激活。LRRC8 在 MSU/CPP 晶体暴露时的激活诱导了 ATP 释放、P2Y 受体激活和细胞内钙增加,这些都是 NLRP3 炎性小体激活和 IL-1β成熟所必需的。我们确定了 LRRC8 对渗透压敏感的阴离子通道在关节晶体诱导的炎症中的一个具有生理病理相关性的功能。